Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates
Lauren Girard(Public Health Agency of Canada), Adam Burgener(Karolinska Institutet), Max Abou(Public Health Agency of Canada), David A. Garber(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Laura Noël‐Romas(Public Health Agency of Canada), Garrett Westmacott(Public Health Agency of Canada), Kenneth E. Palmer(University of Louisville), Stuart McCorrister(Public Health Agency of Canada), Nobuyuki Matoba(University of Louisville), Johanna B. Holm(University of Maryland, Baltimore), Patricia C. Guenthner(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Jacques Ravel(University of Maryland, Baltimore), Mike Humphrys(University of Maryland, Baltimore), Kenzie Birse(Public Health Agency of Canada), Lin Wang(Xijing Hospital), Pawel Gajer(University of Maryland, Baltimore), Janet M. McNicholl(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Lisa C. Rohan(University of Pittsburgh)
Cited by 34
Related Papers
The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women
|Microbiome|2014|872
VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition
|Microbiome|2020|444
The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term
|Microbiome|2014|433
Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery
|Nature Communications|2019|409